| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3943386 | Gynecologic Oncology | 2008 | 6 Pages |
Abstract
PS at diagnosis and relapse within the irradiated area may constitute a valid prognostic model in RMEC patients who receive taxane-based chemotherapy and are able to identify long-term survivors.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
G. Mountzios, A. Bamias, Z. Voulgaris, A. Rodolakis, G. Vlahos, G. Gourgoulis, E. Eleftherakis Papaiakovou, A. Giannopoulos,